TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease

Dettagli Bibliografici
Autori principali:	Culpan, D, Cornish, A, Kehoe, P, Love, S, Wilcock, G
Natura:	Conference item
Pubblicazione:	2004

Documenti analoghi

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
di: Culpan, D, et al.
Pubblicazione: (2009)

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease (vol 30, pg 1052, 2009)
di: Culpan, D, et al.
Pubblicazione: (2010)

Erratum to "TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease" [Culpan et al. (Neurobiol Aging 2009 July;30(7):1052-60)] (DOI:10.1016/j.neurobiolaging.2007.10.014)
di: Culpan, D, et al.
Pubblicazione: (2010)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
di: Culpan, D, et al.
Pubblicazione: (2007)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
di: Chalmers, K, et al.
Pubblicazione: (2004)

The expression of the anti-inflammatory cytokine IL-10 in Alzheimer's disease is independent of IL-10 promoter polymorphisms
di: Culpan, D, et al.
Pubblicazione: (2002)

Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.
di: Kalsoom Sughra, et al.
Pubblicazione: (2010-09-01)

Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease.
di: Culpan, D, et al.
Pubblicazione: (2006)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
di: Miners, J, et al.
Pubblicazione: (2006)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
di: Natalia Ortí-Casañ, et al.
Pubblicazione: (2019-02-01)

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy
di: Miners, J, et al.
Pubblicazione: (2006)

Comprehensive Evolutionary Analysis of Lamprey TNFR-Associated Factors (TRAFs) and Receptor-Interacting Protein Kinase (RIPKs) and Insights Into the Functional Characterization of TRAF3/6 and RIPK1
di: Jianqiang Hou, et al.
Pubblicazione: (2020-04-01)

HLA-DR3 and DQA1*0401: possible risk factors in Alzheimer's disease
di: Culpan, D, et al.
Pubblicazione: (1999)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
di: Culpan, D, et al.
Pubblicazione: (2003)

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
di: Alexandre Ivagnès, et al.
Pubblicazione: (2018-12-01)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
di: Chalmers, K, et al.
Pubblicazione: (2004)

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
di: van Helmond, Z, et al.
Pubblicazione: (2007)

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.
di: Ahmed, A, et al.
Pubblicazione: (1999)

TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
di: Ruspi, G, et al.
Pubblicazione: (2014)

Leukocyte TNFR1 and TNFR2 Expression Contributes to the Peripheral Immune Response in Cases with Ischemic Stroke
di: Rikke B. Hansen, et al.
Pubblicazione: (2021-04-01)

TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
di: Jennifer Wagner, et al.
Pubblicazione: (2025-01-01)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
di: Daniela Siegmund, et al.
Pubblicazione: (2023-11-01)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
di: Harald Wajant, et al.
Pubblicazione: (2019-05-01)

The TRAF2 and TRAF6 expression in myomas and myometrium of women in reproduction and perimenopausal age.
di: Edyta Bogunia, et al.
Pubblicazione: (2010-11-01)

TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
di: Melanie Heinrich, et al.
Pubblicazione: (2015-03-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
di: Kehoe, P, et al.
Pubblicazione: (2007)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
di: Kehoe, P, et al.
Pubblicazione: (1996)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
di: Timon Fiedler, et al.
Pubblicazione: (2023-04-01)

Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes
di: Hijdra Daniëlle, et al.
Pubblicazione: (2012-10-01)

The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease
di: Per Wändell, et al.
Pubblicazione: (2024-11-01)

The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
di: Nurul Hakimah Mohd Salim, et al.
Pubblicazione: (2023-01-01)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
di: Kehoe, P, et al.
Pubblicazione: (2006)

The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
di: Hiroyuki Takahashi, et al.
Pubblicazione: (2022-06-01)

TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease
di: Jagan A. Pillai, et al.
Pubblicazione: (2021-02-01)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
di: Jagan A. Pillai, et al.
Pubblicazione: (2021-06-01)

The TNFR-I and TNFR-II loci in systemic lupus erythematosus
di: Eskdale, J, et al.
Pubblicazione: (1997)

TNFR2: The new Treg switch?
di: Cohen, JL, et al.
Pubblicazione: (2017)

TNFR2: The new Treg switch?
di: José L. Cohen, et al.
Pubblicazione: (2018-01-01)

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.
di: Baig, S, et al.
Pubblicazione: (2005)

TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
di: Ping Liao, et al.
Pubblicazione: (2023-02-01)